QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock

Key Takeaways QGEN partners with GENCURIX to develop oncology assays for the QIAcuityDx digital PCR platform. The pact launches QGEN's QIAcuityDx Partnering Program to broaden its clinical assay ecosystem. GENCURIX will develop and seek approval for assays, which QGEN will market through its global network.QIAGEN N.V. (QGEN) has announced a new partnership with South Korea-based GENCURIX, Inc. to develop oncology assays for use on the QIAcuityDx digital PCR (dPCR) platform. The molecular diagnostics compa ...